|
Trilorale
|
50 mg/ml
|
EU/2/24/313/005
|
Axience, Francija
|
QH02CA01
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
Oral solution
|
| International name (active substance): |
Trilostane
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
06-May-2024
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/24/313/005 |
50 mg/ml |
1 |
Polipropilēna pudele, 36 ml |
-
|
|
|
Equilis Prequenza Te
|
-
|
EU/2/05/057/004
|
Intervet International B.V., Nīderlande
|
QI05AL01
|
horses
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for injection
|
| International name (active substance): |
A/equine-2/Newmarket/1/93,A/equine-2/Newmarket/2/93,A/equine-1/Praque/1/56,Purified haemagglutinin subunits from equine influenza viruses: A/equine-1/Praque/1/56
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Intervet International Booxmer, Nīderlande
|
| Date of authorisation/renewal: |
10-Aug-2006
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/05/057/004 |
|
5 |
Pilnšļirce, 1 deva |
-
|
|
|
UpCard
|
7.50 mg
|
EU/2/15/184/006
|
Vetoquinol S.A., Francija
|
QC03CA04
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
tablets
|
| International name (active substance): |
Torasemide
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Vetoquinol S.A., Francija
|
| Date of authorisation/renewal: |
31-Jul-2015
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/15/184/006 |
7,5 mg |
10 |
PVH/PHTFE alumīnija blisteris, 10 tablete |
[PDF]
|
|
|
QUADRISOL
|
100 mg/ml
|
EU/2/97/005/001
|
VETCOOL B.V., Nīderlande
|
QM01AE90
|
horses
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
Oral Gel
|
| International name (active substance): |
Vedaprofen
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Purna Pharmaceuticals N.V., Beļģija
|
| Date of authorisation/renewal: |
13-Nov-2007
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/97/005/001 |
100 mg/ml |
1 |
Šļirce, 30 ml |
-
|
|
|
BRAVECTO CombiUNO
|
-
|
EU/2/25/350/012
|
Intervet International B.V., Nīderlande
|
QP54AB51
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Fluralaner, Milbemycin oxime
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
30-Jul-2025
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/25/350/012 |
|
6 |
Blisteris, 1 tablete |
-
|
|
|
Tulaven
|
25 mg/ml
|
EU/2/20/251/007
|
Ceva Sante Animale,, Francija
|
QJ01FA94
|
pigs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Tulathromycin
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Ceva Sante Animale,, Francija
|
| Date of authorisation/renewal: |
24-Apr-2020
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/20/251/007 |
|
1 |
Plastmasas flakons, 100 ml |
-
|
|
|
EVICTO
|
360 mg
|
EU/2/19/242/022
|
VIRBAC, Francija
|
QP54AA05
|
dogs 40,1–60,0 kg
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
spot-on solution
|
| International name (active substance): |
Selamectin
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
VIRBAC, Francija
|
| Date of authorisation/renewal: |
19-Jul-2019
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/19/242/022 |
120 mg/ml |
1 |
Polipropilēna pipete, 3 ml |
-
|
|
|
FATROVAX RHD
|
-
|
EU/2/21/275/003
|
Fatro S.p.A., Itālija
|
QI08AA01
|
rabbits
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for injection
|
| International name (active substance): |
Rabbit hemorrhagic disease virus VP1A, Rabbit hemorrhagic disease virus 2 VP1AB
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Fatro S.p.A., Itālija
|
| Date of authorisation/renewal: |
16-Aug-2021
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/21/275/003 |
|
1 |
Polipropilēna flakons, 200 deva |
-
|
|
|
CYTOPOINT
|
30.0 mg/ml
|
EU/2/17/205/006
|
Zoetis Belgium S.A., Beļģija
|
QD11AH91
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Lokivetmab
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Zoetis Belgium S.A., Beļģija
|
| Date of authorisation/renewal: |
26-Apr-2022
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/17/205/006 |
30 mg/ml |
6 |
Stikla flakons, 1 deva |
-
|
|
|
PREVEXXION RN+HVT+IBD
|
0.2 ml
|
EU/2/20/255/003
|
Boehringer Ingelheim Vetmedica GmbH, Vācija
|
QI01AD15
|
chickens
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
concentrate and solvent for suspension for injection
|
| International name (active substance): |
Cell-associated, live recombinant Marek’s disease (MD) virus, serotype 1,strain RN1250, Cell-associated, live recombinant turkey herpesvirus (HVT),expressing the VP2 protein of infectious bursal disease (IBD) virus,strain vHVT013-69
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Boehringer Ingelheim Animal Health France SCS , Francija
|
| Date of authorisation/renewal: |
20-Jul-2020
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/20/255/003 |
|
4 |
Stikla flakons, 4000 deva |
-
|
|
|
Metacam
|
40 mg/ml
|
EU/2/97/004/050
|
Boehringer Ingelheim Vetmedica GmbH, Vācija
|
QM01AC06
|
cattle; horses
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Meloxicam
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Produlab Pharma b.v., Nīderlande
|
| Date of authorisation/renewal: |
20-May-2015
|
| Marketing authorisation valid until: |
19-May-2020
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/97/004/050 |
40 mg/ml |
1 |
Stikla flakons, 50 ml |
-
|
|
|
BTVPUR
|
-
|
EU/2/10/113/003
|
Boehringer Ingelheim Vetmedica GmbH, Vācija
|
QI04AA02;QI02AA08
|
cattle; sheep
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for injection
|
| International name (active substance): |
Bluetongue virus serotype 8 antigen,Bluetongue virus serotype 1 antigen
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
MERIAL, Francija
|
| Date of authorisation/renewal: |
22-Dec-2015
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/10/113/003 |
|
1 |
Polipropilēna pudelīte, 50 deva |
-
|
|
|
Melovem
|
15 mg/ml
|
EU/2/09/098/010
|
Dopharma Research B.V., Nīderlande
|
QM01AC06
|
horses
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Meloxicam
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Dopharma B.V., Nīderlande
|
| Date of authorisation/renewal: |
06-Jun-2014
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/09/098/010 |
|
1 |
ABPE pudele, 500 ml |
-
|
|
|
Suiseng Diff/A
|
-
|
EU/2/21/278/006
|
Laboratorios Hipra S.A., Spānija
|
QI09AB12
|
pigs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for injection
|
| International name (active substance): |
Clostridioides difficile, toxoid A (TcdA), Clostridioides difficile, toxoid B (TcdB), Clostridium perfringens type A, α-toxoid
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Laboratorios Hipra S.A., Spānija
|
| Date of authorisation/renewal: |
07-Dec-2021
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/21/278/006 |
|
1 |
PET flakons, 250 ml/50 deva |
-
|
|
|
Zenrelia
|
6.4 mg
|
EU/2/25/349/004
|
Elanco GmbH, Vācija
|
QD11AH92
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
film-coated tablets
|
| International name (active substance): |
Ilunocitinib
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
24-Jul-2025
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/25/349/004 |
|
1 |
Blisteris, 10 tablete |
-
|
|
|
Melosus
|
1.5 mg/ml
|
EU/2/10/116/001
|
CP-Pharma Handelsgesellschaft GmbH, Vācija
|
QM01AC06
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for oral use
|
| International name (active substance): |
Meloxicam
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Produlab Pharma b.v., Nīderlande
|
| Date of authorisation/renewal: |
07-Jan-2016
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/10/116/001 |
1,5 mg/ml |
1 |
Pudele, 25 ml |
-
|
|
|
Trilorale
|
10 mg/ml
|
EU/2/24/313/002
|
Axience, Francija
|
QH02CA01
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
Oral solution
|
| International name (active substance): |
Trilostane
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
06-May-2024
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/24/313/002 |
10 mg/ml |
1 |
Polipropilēna pudele, 90 ml |
-
|
|
|
Coxatab
|
25 mg
|
EU/2/22/286/004
|
CP-Pharma Handelsgesellschaft GmbH, Vācija
|
QM01AH90
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
Chewable tablet
|
| International name (active substance): |
Firocoxib
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
CP-Pharma Handelsgesellschaft GmbH, Vācija
|
| Date of authorisation/renewal: |
12-Aug-2022
|
| Marketing authorisation valid until: |
11-Aug-2027
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/22/286/004 |
25 mg/tabl. |
1 |
alumīnija/PVC/PE/PVDC blisteris, 50 tablete |
-
|
|
|
Purevax RCPCh
|
-
|
EU/2/04/050/004
|
Boehringer Ingelheim Vetmedica GmbH, Vācija
|
QI06AJ03
|
cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
lyophilisate and solvent for suspension for injection
|
| International name (active substance): |
Attenuated feline rhinotracheitis herpesvirus,Inactivated feline panleucopenia virus,Attenuated Chlamydophila felis,Inactivated feline Calicivirosis antigens
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Boehringer Ingelheim Animal Health France SCS, Francija
|
| Date of authorisation/renewal: |
12-Mar-2021
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/04/050/004 |
|
50 |
Stikla pudele, 1 deva |
-
|
|
|
Metacam
|
20 mg/ml
|
EU/2/97/004/032
|
Boehringer Ingelheim Vetmedica GmbH, Vācija
|
QM01AC06
|
cattle; pigs; horses
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Meloxicam
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Labiana Life Sciences S.A., Spānija
|
| Date of authorisation/renewal: |
06-Dec-2007
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/97/004/032 |
20 mg/ml |
6 |
Stikla flakons, 250 ml |
-
|
|